Actinium Pharmaceuticals Inc
$ 1.15
0.88%
26 Feb - close price
- Market Cap 35,563,300 USD
- Current Price $ 1.15
- High / Low $ 1.17 / 1.11
- Stock P/E N/A
- Book Value 0.44
- EPS -1.18
- Next Earning Report 2026-03-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.34 %
- ROE -1.33 %
- 52 Week High 2.41
- 52 Week Low 1.02
About
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of cell therapy, and for other adoptive cell therapies. The company is headquartered in New York, New York.
Analyst Target Price
$5.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-24 | 2025-08-08 | 2025-04-24 | 2025-03-27 | 2024-10-31 | 2024-08-05 | 2024-04-26 | 2024-03-29 | 2023-11-02 | 2023-08-14 | 2023-05-15 | 2023-03-31 |
| Reported EPS | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 | -0.58 | -0.43 | -0.43 |
| Estimated EPS | -0.3175 | -0.348 | -0.2775 | -0.39 | -0.3667 | -0.4 | -0.52 | -0.54 | -0.53 | -0.48 | -0.42 | -0.35 |
| Surprise | 0.1575 | 0.128 | -0.2325 | 0.18 | -0.0033 | 0.02 | 0.21 | 0.2 | 0.04 | -0.1 | -0.01 | -0.08 |
| Surprise Percentage | 49.6063% | 36.7816% | -83.7838% | 46.1538% | -0.8999% | 5% | 40.3846% | 37.037% | 7.5472% | -20.8333% | -2.381% | -22.8571% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-30 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.2 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
